SOT annual meeting 2023

Bio-Europe 2022

Colloque Meetochondries

Hepatotoxicity evaluation: how to spot early adverse effects on mitochondria?

Our latest brochure is now available for downloading.

Bio-Europe Spring 2020

Mitologics will be present at Bio-Europe Spring, March 23-25, 2020, Paris (France).

Meet us at the Partnering session and Medicen Paris-Region booth #75

SOT annual meeting 2020

Mitologics will be present at SOT, March 15-19, 2020, Anaheim (California).

Poster #1970/ P277: Drug-Induced Impairment of Mitochondrial Fatty Acid Oxidation and Steatosis: Assessment of Causal Relationship with 45 Pharmaceuticals.

Presented by Annie Borgne-Sanchez on March 17, 2020 2:15 - 4:30 PM

Press release

MITOLOGICS to collaborate in RespiriTB RespiriNTM consortium project awarded by the European Innovative Medicines Initiative to develop new antibiotics. Press release

October 2019

 Cosmetic-360. Oct 16-17, 2019, Paris (France) - Booth ST26

July 2019

 AFSSI UE 2019. July 2-3, 2019, Lyon (France)

May 2019

 MEET2WIN Oncology Business Convention, Bordeaux (France), May 21-22, 2019.

March 2019

 AACR Annual meeting, Atlanta, USA, March 29 - Apr 3, 2019

September 2018

 Eurotox 2018, Brussels, September 2-5, 2018

May 2018

MEET2WIN Oncology Business Convention, Bordeaux (France), May 17-18, 2018.

MeetOchondrie congress, Pornichet (France), May 27-30, 2018

March 2018

57^th Annual Meeting of the Society of Toxicology, March 11–15, 2018, San Antonio, Texas.

Meet Mitologics at the following poster sessions:

Poster 1546/P772:  Identification of Potential Cardiotoxic Drugs Using Isolated Rat Heart Mitochondria
Presented by Annie Borgne-Sanchez on March 12, 2018 1:30 - 3:00 PM

November 2017

Bio-Europe 2017. November 6-7, 2017, Berlin (Germany)

October 2017

Cosmetic 360. October 18-19, 2017, Paris (France)

July 2017

AFSSI UE 2017. July 11-13, 2017, Marseille (France)

Reseau MeetOchondries May 14 - 17, 2017

Mitologics CEO, Dr Annie Borgne-Sanchez is invited speaker at the next meeting of the Réseau MeetOchondries, taking place May 14-17, 2017 in Hossegor (France). Title: Impact des médicaments contaminants environnementaux sur les fonctions mitochondriales et le métabolisme

BIO EUROPE Nov 7 - 9, 2016

Mitologics will attend BIO EUROPE in Köln November 7 to 9th, 2016

Top of the page 

7th World Congress on Mitochondrial Targeting, 24-26 October 2016 Berlin, Germany

Mitologics will attend the 7^th World Congress on Mitochondrial Targeting, 24-26 October 2016 Berlin, Germany

Top of the page 

Innovation Days October 3-4, 2016

Mitologics will be present at Innovation Days in Paris (France) in October 3-4, 2016

Top of the page 

Strategic partnership with Toxys - March 2016

Toxys and Mitologics announce a strategic partnership to jointly offer their unique in vitro toxicity assays. The unique combination of the ToxTracker® assay and the MiToxView® platform provides a valuable approach for reliable identification of the hazardous properties of new compounds and nanomaterials and gain insight into their mechanisms of action.

Top of the page 

March 2016

Society of Toxicology 55th Annual Meeting and ToxExpo March 13–17, 2016

Society of Toxicology 55th Annual Meeting and ToxExpo March March 13 - 17, 2016

The attendees of the next Society of Toxicology 55th Annual Meeting and ToxExpo, March 13–17, 2016, in New Orleans, Louisiana, are invited to meet Mitologics' team at booth 327. Mitologics will present the last developments of its screening toxicity platform MiToxView during 2 poster sessions: 1-In vitro prediction of antiretroviral drug-induced hepatotoxicity by using mitochondrial MiToxView® screening platform. 2-Exploration of drug-induced mitochondrial toxicity mechanisms on hepatic mitochondria and cultured cells (presented by L'Oréal).

Top of the page 

October 2015

Mitologics is sponsor of the 6th World Congress on Targeting Mitochondria, taking place October 28-30, 2015 in Berlin, Germany. The company will present its new R&D datas on MiToxView predictive toxicology platform.

May 2015

Mitologics CEO, Dr Annie Borgne-Sanchez is invited speaker at the next meeting of the Réseau MeetOchondries, taking place May 10-13, 2015 in Guidel, (France). Title: Combinaison de tests sur mitochondries isolées et cellules HepaRG pour la prédiction des risques d’hépatotoxicité chez l’homme.

January 2015

Mitologics CEO, Dr Annie Borgne-Sanchez is invited speaker at the next Targeting Mitochondrial Dysfunction and Toxicity Conference (CHI), taking place March 19-20, 2015 in Cambridge, MA (USA). Title: Use of Multiparametric Assays on Isolated Liver Mitochondria and HepaRG Cells to predict DILI.

August 2014

Mitologics will present its new R&D datas on predictive toxicology at the EUROTOX 2013 Congress, September 1-4, 2013 in Interlaken (CH): "Prediction of Drug-Induced Liver Injury in Human with a Multiparametric Assay on the HepaRG® Cell Line" P12-64.

September 2014

Annie Borgne-Sanchez will present Mitologics' latest results on HepaRG model:
"Identification of drug-induced mitochondrial alterations using the HepaRG cell line"
At the 19th North America ISSX meeting - October 19-23, 2014 - San Francisco, CA, USA.

October 2013

BAYER Oncology department published new datas generated on Mitologics screening platform : BAY 87-2243, a highly potent and selective inhibitor of hypoxia-induced gene activation has antitumor activities by inhibition of mitochondrial complex I. Ellinghaus P et al., 2013 in Cancer Med 2(5):611-24.